The Impact of Adherence to Screening Guidelines and of Diabetes Clinics Referral on Morbidity and Mortality in Diabetes

被引:48
|
作者
Giorda, Carlo [1 ]
Picariello, Roberta [2 ]
Nada, Elisa [3 ]
Tartaglino, Barbara [3 ]
Marafetti, Lisa [1 ]
Costa, Giuseppe [2 ,4 ]
Gnavi, Roberto [2 ]
机构
[1] ASL TO5, Metab & Diabet Unit, Chieri, Regione Piemont, Italy
[2] ASL TO3, Epidemiol Unit, Grugliasco, Regione Piemont, Italy
[3] Chaira Med Assoc, Chieri, Italy
[4] Univ Turin, Dept Publ Hlth, Turin, Italy
来源
PLOS ONE | 2012年 / 7卷 / 04期
关键词
QUALITY-OF-CARE; OUTCOMES; CANCER;
D O I
10.1371/journal.pone.0033839
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Despite the heightened awareness of diabetes as a major health problem, evidence on the impact of assistance and organizational factors, as well as of adherence to recommended care guidelines, on morbidity and mortality in diabetes is scanty. We identified diabetic residents in Torino, Italy, as of 1st January 2002, using multiple independent data sources. We collected data on several laboratory tests and specialist medical examinations to compare primary versus specialty care management of diabetes and the fulfillment of a quality-of-care indicator based on existing screening guidelines (GCI). Then, we performed regression analyses to identify associations of these factors with mortality and cardiovascular morbidity over a 4 year-follow-up. Patients with the lowest degree of quality of care (i.e. only cared for by primary care and with no fulfillment of GCI) had worse RRs for all-cause (1.72 [95% CI 1.57-1.89]), cardiovascular (1.74 [95% CI 1.50-2.01]) and cancer (1.35 [95% CI 1.14-1.61]) mortality, compared with those with the highest quality of care. They also showed increased RRs for incidence of major cardiovascular events up to 2.03 (95% CI 1.26-3.28) for lower extremity amputations. Receiving specialist care itself increased survival, but was far more effective when combined with the fulfillment of GCI. Throughout the whole set of analysis, implementation of guidelines emerged as a strong modifier of prognosis. We conclude that management of diabetic patients with a pathway based on both primary and specialist care is associated with a favorable impact on all-cause mortality and CV incidence, provided that guidelines are implemented.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Comparison of the adherence to the american diabetes association guidelines of diabetes care in primary care and subspecialty clinics
    Rao D.T.
    Sunio L.K.
    Lo Y.-J.
    Gossain V.V.
    Journal of Diabetes & Metabolic Disorders, 14 (1):
  • [2] Impact of covid-19 pandemic on diabetes referral to secondary care diabetes clinics
    Latheef, M.
    Essame, J.
    Min, T.
    DIABETIC MEDICINE, 2022, 39
  • [3] The Impact of Diabetes on Morbidity and Mortality Following Thyroidectomy
    Patel, Roshan V.
    Randhawa, Avneet
    Randhawa, Karandeep S.
    Aftab, Owais M.
    Khawaja, Imran M.
    Hegazin, Michael
    Eloy, Jean Anderson
    Fang, Christina H.
    LARYNGOSCOPE, 2023, 133 (12): : 3628 - 3632
  • [4] Adherence to the American Diabetes Association retinal screening guidelines for population with diabetes in the United States
    An, JaeJin
    Niu, Fang
    Turpcu, Adam
    Rajput, Yamina
    Cheetham, T. Craig
    OPHTHALMIC EPIDEMIOLOGY, 2018, 25 (03) : 257 - 265
  • [5] Adherence to 1997 diabetes screening guidelines in a large ambulatory clinic
    Koll, E
    Hewitt, JB
    DIABETES EDUCATOR, 2001, 27 (03): : 387 - 392
  • [6] Impact of glucose level on morbidity and mortality in elderly with diabetes and pre-diabetes
    Twito, Orit
    Frankel, Meir
    Nabriski, Dan
    WORLD JOURNAL OF DIABETES, 2015, 6 (02) : 345 - 351
  • [7] Impact of type 2 diabetes and/or MASLD on morbidity and mortality
    Kahl, S.
    DIABETOLOGIE, 2024, 20 (06): : 754 - 755
  • [8] Diabetes and CVD: Impact of antidiabetic agents on morbidity and mortality
    不详
    Nature Clinical Practice Cardiovascular Medicine, 2008, 5 (1): : 6 - 9
  • [9] Diabetes and CVD: impact of antidiabetic agents on morbidity and mortality
    Nature Clinical Practice Endocrinology & Metabolism, 2008, 4 (1): : 6 - 6
  • [10] Morbidity and mortality of diabetes with surgery
    Chuah, L. L.
    Papamargaritis, D.
    Pillai, D.
    Krishnamoorthy, A.
    le Roux, C. W.
    NUTRICION HOSPITALARIA, 2013, 28 : 47 - 52